IP Library Granted Patent US 10,081,544
Granted Patent B2
US 10,081,544 · App. 15/645,197 · Granted Sep 25, 2018

Conversion of nitrogen dioxide (NO

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,081,544
App. No.
15/645,197
Granted
Sep 25, 2018
Kind
B2
Abstract

Various systems, devices, NO 2 absorbents, NO 2 scavengers and NO 2 recuperator for generating nitric oxide are disclosed herein. According to one embodiment, an apparatus for converting nitrogen dioxide to nitric oxide can include a receptacle including an inlet, an outlet, a surface-active material coated with an aqueous solution of ascorbic acid and an absorbent wherein the inlet is configured to receive a gas flow and fluidly communicate the gas flow to the outlet through the surface-active material and the absorbent such that nitrogen dioxide in the gas flow is converted to nitric oxide.

Claims (18)

1. A method for delivering nitric oxide to a patient, comprising:

supplying:

a gas source of nitrogen dioxide, dinitrogen tetraoxide, or nitric oxide;

a first device having an inlet, an outlet, and a porous solid matrix positioned between the inlet and the outlet, wherein the porous solid matrix is coated with an aqueous solution of an antioxidant, and wherein the inlet is configured to receive a gas flow from the source and fluidly communicate the gas flow to the outlet through the porous solid matrix to convert nitrogen dioxide in the gas flow into nitric oxide; and

a recuperator coupled to the outlet of the first device, wherein the recuperator includes an exit shell and an inside shell, the inside shell includes inner and outertubes with a fixed annulus and a reducing agent between the inner and outer tubes;

converting nitrogen dioxide into nitric oxide in the recuperator prior to delivery to the patient; and

delivering nitric oxide to the patient.

2. The method of claim 1 , wherein the recuperator has a flow resistance of less than 3 cm of water pressure at a flow of 60 L/minute.

3. The method of claim 1 , wherein the recuperator has a flow resistance of less than 1 cm water at 15 L/min.

4. The method of claim 1 , wherein the recuperator is operated at atmospheric pressure.

5. The method of claim 1 , wherein the recuperator has an oxygen concentration of in the range of 21 to 100%.

6. The method of claim 1 , wherein the recuperator has a humidity of dry to 99%.

7. The method of claim 1 , wherein the recuperator is thermally insulated.

8. The method of claim 1 , wherein the recuperator is coupled to the outlet of the first device through a humidified line.

9. The method of claim 7 , wherein the humidified line is heated.

10. The method of claim 8 , wherein the humidified line is heated to about 35° C.

11. The method of claim 1 , wherein the recuperator is coupled to a NO/NO 2 gas analyzer.

12. The method of claim 1 , wherein the recuperator further comprises a particle filter.

Assignments (10)
RELEASE OF SECURITY INTEREST Recorded Mar 18, 2026
From: HORIZON TECHNOLOGY FINANCE CORPORATION
To: VERO BIOTECH INC.
Reel/Frame 075308/0198 →
SECURITY INTEREST Recorded Mar 16, 2026
From: VERO BIOTECH INC.
To: SYMBIOTIC CAPITAL AGENCY LLC, AS COLLATERAL AGENT
Reel/Frame 075117/0935 →
TERMINATION AND RELEASE OF INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Jan 3, 2024
From: RUNWAY GROWTH FINANCE CORP (F/K/A RUNWAY GROWTH CREDIT FUND INC.)
To: VERO BIOTECH INC. (F/K/A VERO BIOTECH LLC)
Reel/Frame 066186/0611 →
SECURITY INTEREST Recorded Jan 3, 2024
From: VERO BIOTECH INC.
To: HORIZON TECHNOLOGY FINANCE CORPORATION
Reel/Frame 066187/0865 →
CHANGE OF NAME Recorded Dec 23, 2022
From: GENO LLC
To: VERO BIOTECH LLC
Reel/Frame 062218/0787 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 23, 2022
From: FINE, DAVID; VASQUEZ, GREGORY; ROUNBEHLER, DAVID
To: GENO LLC
Reel/Frame 062198/0024 →
CHANGE OF NAME Recorded Feb 14, 2022
From: VERO BIOTECH LLC
To: VERO BIOTECH INC.
Reel/Frame 059085/0418 →
SECURITY INTEREST Recorded Dec 29, 2020
From: VERO BIOTECH LLC
To: RUNWAY GROWTH CREDIT FUND INC.
Reel/Frame 054866/0589 →
CORRECTIVE ASSIGNMENT TO CORRECT THE THE ASSIGNMENT WAS RECORDED UNDER THE INCORRECT USSN 15/035,223. SHOULD BE UNDER USSN 15/645,197 PREVIOUSLY RECORDED ON REEL 046641 FRAME 0616. ASSIGNOR(S) HEREBY CONFIRMS THE PLEASE RECORDS UNDER USSN 15/645,197. Recorded Aug 31, 2018
From: FINE, DAVID H.; VASQUEZ, GREGORY; ROUNBEHLER, DAVID P.
To: VERO BIOTECH LLC
Reel/Frame 046989/0567 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 21, 2018
From: FINE, DAVID H.; VASQUEZ, GREGORY; ROUNBEHLER, DAVID P.
To: VERO BIOTECH LLC
Reel/Frame 046641/0616 →
Cited By (6)
US 12,509,349 US 12,522,501 US 12,569,628 US 12,576,234 US 12,606,436 US 12,661,477